Monoclonal antibody therapy is complicated by the potential for the human immune system to form antibodies to these drugs. Antibodies can be formed to the Fv and Fc regions or to murine epitopes.

aggressive hyperinflammatory condition—who were treated with the first-in-class monoclonal antibody, ELA026, experienced a 100% response rate and an improved survival rate at two months ...

This class of treatment — monoclonal antibodies, special artificial proteins that carry instructions to the body’s immune system — have the potential to be a genuine all-in-one allergy ...

The company became practically a household name when its monoclonal antibody COVID-19 therapy REGEN-COV2 was used to treat President Donald Trump in 2020 during his first presidential term.

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its ...

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.

“Similarly, there is an unmet medical need for treatment, a need which IgGenix is hoping to address.” IgE, which is a specific class of monoclonal antibody, triggers reactions after people are ...

Antibodies obtained from llamas may be adapted ... can kill the new virus and scientists think they can adapt it for a treatment that would provide the same kind of results as a plasma transfusion ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...

Title: Switching to Ublituximab from Prior anti-CD20 Monoclonal Antibody Therapy: A Case Report Series The article describes a retrospective case series of seven individuals with multiple ...